Aptevo Therapeutics Inc (APVO) stock news · rev $3.1M
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
This APVO news page leads with what Aptevo Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for APVO yet. We will not pad this page with generic market recap.
Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the APVO stock page; for the tape open the quote page.
APVO stock news FAQ
What are APVO's latest revenue and net income?
Latest cached Aptevo Therapeutics Inc (APVO) revenue for Dec 31, 2022 was $3.1M. Net income was $8.0M. Statements: https://lician.com/financials/apvo
What is APVO's market cap?
Aptevo Therapeutics Inc (APVO) market cap is $9.9M on the latest cached fundamentals snapshot.
What kind of company is APVO?
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Where is APVO stock news listed?
Cached stock news for Aptevo Therapeutics Inc (APVO) is listed at https://lician.com/news/apvo. Filings: https://lician.com/sec/apvo
Not investment advice.